These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2955843)

  • 1. The effect of GR38032F, novel 5-HT3-receptor antagonist on gastric emptying in the guinea-pig.
    Costall B; Gunning SJ; Naylor RJ; Tyers MB
    Br J Pharmacol; 1987 Jun; 91(2):263-4. PubMed ID: 2955843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of ondansetron on gastric emptying in the conscious rat.
    Forster ER; Dockray GJ
    Eur J Pharmacol; 1990 Nov; 191(2):235-8. PubMed ID: 2150819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the 5-HT3 receptor antagonist properties of ICS 205-930, GR38032F and zacopride.
    Cohen ML; Bloomquist W; Gidda JS; Lacefield W
    J Pharmacol Exp Ther; 1989 Jan; 248(1):197-201. PubMed ID: 2521513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colonic transit in man is slowed by ondansetron (GR38032F), a selective 5-hydroxytryptamine receptor (type 3) antagonist.
    Gore S; Gilmore IT; Haigh CG; Brownless SM; Stockdale H; Morris AI
    Aliment Pharmacol Ther; 1990 Apr; 4(2):139-44. PubMed ID: 2151757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological properties of GR38032F, a novel antagonist at 5-HT3 receptors.
    Butler A; Hill JM; Ireland SJ; Jordan CC; Tyers MB
    Br J Pharmacol; 1988 Jun; 94(2):397-412. PubMed ID: 2969267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-Hydroxytryptamine3 receptor and regulation of gastric emptying in rats.
    Ito C; Isobe Y; Tsuchida K; Higuchi S
    Arch Int Pharmacodyn Ther; 1996; 331(2):203-18. PubMed ID: 8937630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GR38032F, a serotonin 5-HT3 antagonist, fails to alter cocaine self-administration in rats.
    Peltier R; Schenk S
    Pharmacol Biochem Behav; 1991 May; 39(1):133-6. PubMed ID: 1833779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of serotonin (5-HT)3-receptor antagonists YM060, YM114 (KAE-393), ondansetron and granisetron on 5-HT4 receptors and gastric emptying in rodents.
    Miyata K; Yamano M; Kamato T; Akuzawa S
    Jpn J Pharmacol; 1995 Nov; 69(3):205-14. PubMed ID: 8699628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of serotonin-3 receptor antagonist activity to gastric emptying and motor-stimulating actions of prokinetic drugs in dogs.
    Gullikson GW; Loeffler RF; Viriña MA
    J Pharmacol Exp Ther; 1991 Jul; 258(1):103-10. PubMed ID: 2072288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the 5-HT3 receptor antagonist, GR38032F, on raised dopaminergic activity in the mesolimbic system of the rat and marmoset brain.
    Costall B; Domeney AM; Naylor RJ; Tyers MB
    Br J Pharmacol; 1987 Dec; 92(4):881-94. PubMed ID: 2962686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5-Hydroxytryptamine receptor antagonism by metoclopramide and ICS 205-930 in the guinea-pig leads to enhancement of contractions of stomach muscle strips induced by electrical field stimulation and facilitation of gastric emptying in-vivo.
    Buchheit KH; Costall B; Engel G; Gunning SJ; Naylor RJ; Richardson BP
    J Pharm Pharmacol; 1985 Sep; 37(9):664-7. PubMed ID: 2867192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LY277359 maleate: a potent and selective 5-HT3 receptor antagonist without gastroprokinetic activity.
    Cohen ML; Bloomquist W; Gidda JS; Lacefield W
    J Pharmacol Exp Ther; 1990 Jul; 254(1):350-5. PubMed ID: 2366187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacology and preclinical antiemetic properties of ondansetron.
    Tyers MB
    Semin Oncol; 1992 Aug; 19(4 Suppl 10):1-8. PubMed ID: 1387245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Y-25130, a selective 5-hydroxytryptamine3 receptor antagonist, on gastric emptying in mice.
    Haga K; Asano K; Inaba K; Morimoto Y; Setoguchi M
    Arch Int Pharmacodyn Ther; 1994; 328(3):344-55. PubMed ID: 7625886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Participation of a cholinergic mechanism in 5-hydroxytryptamine (5-HT)3 and 5-HT4 receptor-mediated stimulation of gastric emptying in rats.
    Yamano M; Kamato T; Miyata K
    Arzneimittelforschung; 1997 Nov; 47(11):1242-6. PubMed ID: 9428982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The gastrointestinal motor effect of benzamide derivatives is unrelated to 5-HT3 receptor blockade.
    Schiavone A; Volonté M; Micheletti R
    Eur J Pharmacol; 1990 Oct; 187(3):323-9. PubMed ID: 2073919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physiological and pharmacological properties of 5-HT3 receptors--a patch clamp-study.
    Malone HM; Peters JA; Lambert JJ
    Neuropeptides; 1991 Jul; 19 Suppl():25-30. PubMed ID: 1715528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of a novel 5-hydroxytryptamine3-antagonist, GR38032F, on the 5-hydroxytryptamine-induced increase in carotid sinus nerve activity in rats.
    Yoshioka M
    J Pharmacol Exp Ther; 1989 Aug; 250(2):637-41. PubMed ID: 2527299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of enhancement and antagonism of 5-hydroxytryptamine activity on the influence of metoclopramide on gastric emptying.
    van Wyk M; Sommers DK; Moncrieff J
    Digestion; 1993; 54(1):40-3. PubMed ID: 8513986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A central site of action for benzamide facilitation of gastric emptying.
    Costall B; Gunning SJ; Naylor RJ; Simpson KH
    Eur J Pharmacol; 1983 Jul; 91(2-3):197-205. PubMed ID: 6617741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.